Bayer Appoints New Consumer Health CMO for North America

  Rassegna Stampa, Social
image_pdfimage_print

Shareholders want a solution to the financial woes that have plagued Bayer AG since its $63 billion 2018 takeover of chemical company Monsanto.

For now, though, CEO Bill Anderson has ruled out a spinoff, instead making changes to the company’s operating model to instigate a turnaround.

Enjoying Adweek’s Content? Register for More Access!

Recommended articles

https://www.adweek.com/brand-marketing/bayer-appoints-new-consumer-health-cmo-for-north-america/

Pagine: 1 2